3//SEC Filing
SVLSF VI, LLC 3
Accession 0001567619-19-019312
CIK 0000880432other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 5:20 PM ET
Size
13.2 KB
Accession
0001567619-19-019312
Insider Transaction Report
Form 3
MISONIX INCMSON
SVLSF VI, LLC
10% Owner
Holdings
- 56,143(indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Common Stock
- 1,639,826(indirect: By: SV Life Sciences Fund VI, L.P.)
Common Stock
SV Life Sciences Fund VI, L.P.
10% Owner
Holdings
- 1,639,826(indirect: By: SV Life Sciences Fund VI, L.P.)
Common Stock
- 56,143(indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Common Stock
SV Life Sciences Fund VI (GP), L.P.
10% Owner
Holdings
- 1,639,826(indirect: By: SV Life Sciences Fund VI, L.P.)
Common Stock
- 56,143(indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Common Stock
Holdings
- 56,143(indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Common Stock
- 1,639,826(indirect: By: SV Life Sciences Fund VI, L.P.)
Common Stock
Footnotes (4)
- [F1]Acquired pursuant to the Agreement and Plan of Merger between Misonix, Inc., New Misonix, Inc., Motor Reincorp. Sub One, Inc., Surge Sub Two, LLC, Solsys Medical, LLC ("Solsys"), and Greg Madden solely in his capacity as representative, in exchange for 27,116,608 Series E Preferred Units of Solsys. The Merger Agreement placed a value on the issuer's common stock of $18.5479, which reflects the 10-day VWAP for the issuer's common stock as of three business days prior to the effective date of the merger.
- [F2]These shares are owned directly by SV Life Sciences Fund VI, L.P. ("SVLS VI LP"). 199,617 of the shares issued to SVLS VI LP are being held in escrow and are subject to forfeiture during the 15 month-period following the merger to satisfy any post-closing purchase price adjustments and indemnification claims. SV Life Sciences Fund VI (GP), L.P. ("SVLS VI GP"), the general partner of SVLS VI LP, may be deemed to share voting and dispositive power over the shares held by SVLS VI LP. SVLS VI GP disclaims beneficial ownership of shares held by SVLS VI LP except to the extent of any pecuniary interests therein.
- [F3]These shares are owned directly by SV Life Sciences Fund VI Strategic Partners, L.P. ("Strategic Partners"). 6,834 of the shares issued to Strategic Partners are being held in escrow and are subject to forfeiture during the 15 month-period following the merger to satisfy any post-closing purchase price adjustments and indemnification claims. SVLS VI GP, the general partner of Strategic Partners, may be deemed to share voting and dispositive power over the shares held by Strategic Partners. SVLS VI GP disclaims beneficial ownership of shares held by Strategic Partners except to the extent of any pecuniary interests therein.
- [F4]SVLS VI LP and Strategic Partners (each a "Fund," or collectively the "Funds") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein.
Documents
Issuer
MISONIX INC
CIK 0000880432
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001717728
Filing Metadata
- Form type
- 3
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 5:20 PM ET
- Size
- 13.2 KB